Skip to main content
Professional Technical IVT

pediatric lupus

Also written as: pSLE — pediatric systemic lupus erythematosus

Systemic lupus erythematosus occurring in children, typically presenting with more severe disease than adult-onset lupus.

Full Definition

Pediatric systemic lupus erythematosus (pSLE) affects approximately 10-20% of all lupus patients, with onset before age 18 years. Childhood-onset lupus typically presents with more aggressive disease, higher rates of renal and neuropsychiatric involvement, and greater accumulated organ damage compared to adult-onset disease. Common presenting features include constitutional symptoms, arthritis, rash, and cytopenias. Lupus nephritis occurs in 60-80% of pediatric patients compared to 40-50% in adults. The disease course is often characterized by periods of flare and remission, requiring aggressive immunosuppressive therapy and careful monitoring for treatment-related toxicities during critical developmental periods.

Usage

Usage note: Always specify 'pediatric' or 'childhood-onset' to distinguish from adult SLE in clinical documentation.

In Context

  • "The adolescent presented with pediatric lupus complicated by Class IV lupus nephritis requiring aggressive immunosuppression." — Case presentation
  • "Neuropsychiatric manifestations are more common in pediatric lupus than in adult-onset disease." — Clinical review

Also known as

pSLE childhood-onset SLE

Don't confuse with

mixed connective tissue disease juvenile dermatomyositis

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON